Literature DB >> 7268794

Plasma phenylalanine levels in phenylketonuric heterozygous and normal adults administered aspartame at 34 mg/kg body weight.

L D Stegink, R Koch, M E Blaskovics, L J Filer, G L Baker, J E McDonnell.   

Abstract

Following administration of aspartame (34 mg/kg body wt) in orange juice, plasma concentrations of free amino acids were measured in 12 female subjects known to be heterozygous for phenylketonuria and 22 normal subjects (12 male, 10 female). No change in fasting plasma aspartate concentrations were noted after aspartame loading in either group. In normal male subjects, the mean (+/-S.D.) plasma phenylalanine concentration increased from a fasting value of 5.86 +/- 1.25 mumol/dl. Plasma phenylalanine levels in normal female subjects increased from a mean fasting concentration of 4.83 +/- 0.84 mumol/dl to a men peak value of 8.95 +/- 1.49 mumol/dl suggesting a more rapid absorption, metabolism, and/or clearance of phenylalanine by females. In female heterozygous subjects, the mean peak plasma phenylalanine concentration was significantly higher than in normal females. Plasma phenylalanine values increased from a mean fasting value of 5.92 +/- 1.51 mumol/dl to a mean peak value of 15.1 +/- 4.76 mumol/dl. Similarly, the area under the plasma phenylalanine concentration-time curve was significantly greater in heterozygous female subjects (21.36 +/- 5.10 IU) than in normal female subjects (10.84 +/- 2.32 IU). However, peak plasma phenylalanine levels were well below those associated with toxic effects in all cases.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7268794     DOI: 10.1016/0300-483x(81)90108-6

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  5 in total

1.  Metabolome-wide association study of phenylalanine in plasma of common marmosets.

Authors:  Young-Mi Go; Douglas I Walker; Quinlyn A Soltow; Karan Uppal; Lynn M Wachtman; Fredrick H Strobel; Kurt Pennell; Daniel E L Promislow; Dean P Jones
Journal:  Amino Acids       Date:  2014-12-21       Impact factor: 3.520

Review 2.  Inherited metabolic diseases affecting the carrier.

Authors:  W Endres
Journal:  J Inherit Metab Dis       Date:  1997-03       Impact factor: 4.982

Review 3.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

4.  Accidental Consumption of Aspartame in Phenylketonuria: Patient Experiences.

Authors:  Ella Newbould; Alex Pinto; Sharon Evans; Suzanne Ford; Mike O'Driscoll; Catherine Ashmore; Anne Daly; Anita MacDonald
Journal:  Nutrients       Date:  2021-02-23       Impact factor: 5.717

5.  A study of common Mendelian disease carriers across ageing British cohorts: meta-analyses reveal heterozygosity for alpha 1-antitrypsin deficiency increases respiratory capacity and height.

Authors:  Teri-Louise North; Yoav Ben-Shlomo; Cyrus Cooper; Ian J Deary; John Gallacher; Mika Kivimaki; Meena Kumari; Richard M Martin; Alison Pattie; Avan Aihie Sayer; John M Starr; Andrew Wong; Diana Kuh; Santiago Rodriguez; Ian N M Day
Journal:  J Med Genet       Date:  2016-02-01       Impact factor: 6.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.